MIDAS Research Initiates Coverage of Arrowhead Research Corp.

Jan 12, 2005, 00:00 ET from MIDAS Research

    MANNHEIM, Germany, January 12 /PRNewswire/ -- MIDAS Research has
 published a research report on the nanotechnology company Arrowhead Research
 Corp. (Nasdaq:   ARWR / Berlin Exchange: HDP) with a 12 month target of USD
 6.00 and a speculative buy recommendation. A copy of the report is available
 in both German and English at www.midasresearch.de .
     Arrowhead Research is developing products and intellectual property in a
 number of nanotech fields including novel drug delivery systems,
 semiconductor materials and tools for atomic force microscopy.
     As judged by the breadth and diversity of Arrowheads intellectual
 property the company is likely to gain much broader attention by investors
 concludes MIDAS Research technology analyst Karsten Siebert, CEFA, in his
 report.
     MIDAS Research is an independent stock research company with a global
 focus on emerging industries like nanotech and biotech. Recent reports have
 successfully highlighted stocks like MorphoSys (GER), pSivida (AUS), Callisto
 Pharma (USA) or EpiTan (AUS).
 
     For further information please contact:
 
     Michael Drepper,
     Info@midas-research.de,
     +49-621-4306130
 
 
 

SOURCE MIDAS Research
    MANNHEIM, Germany, January 12 /PRNewswire/ -- MIDAS Research has
 published a research report on the nanotechnology company Arrowhead Research
 Corp. (Nasdaq:   ARWR / Berlin Exchange: HDP) with a 12 month target of USD
 6.00 and a speculative buy recommendation. A copy of the report is available
 in both German and English at www.midasresearch.de .
     Arrowhead Research is developing products and intellectual property in a
 number of nanotech fields including novel drug delivery systems,
 semiconductor materials and tools for atomic force microscopy.
     As judged by the breadth and diversity of Arrowheads intellectual
 property the company is likely to gain much broader attention by investors
 concludes MIDAS Research technology analyst Karsten Siebert, CEFA, in his
 report.
     MIDAS Research is an independent stock research company with a global
 focus on emerging industries like nanotech and biotech. Recent reports have
 successfully highlighted stocks like MorphoSys (GER), pSivida (AUS), Callisto
 Pharma (USA) or EpiTan (AUS).
 
     For further information please contact:
 
     Michael Drepper,
     Info@midas-research.de,
     +49-621-4306130
 
 
 SOURCE  MIDAS Research